Vecuronium infusion requirements in paediatric patients in intensive care units: The use of acceleromyography

British Journal of Anaesthesia

Volumn 76, Issue 1, 1996, Pages 23-28

  Hodges, U M ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b ST ANDREW S HOSPITAL   (United Kingdom)

Author keywords

Infants; Intensive care; Measurement techniques, acceleromyography; Monitoring, neuromuscular function; Neuromuscular block, vecuronium

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; VECURONIUM;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG INFUSION; DRUG MONITORING; DRUG OVERDOSE; HUMAN; INFANT; INTENSIVE CARE; MUSCLE WEAKNESS; MYOGRAPHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; NEWBORN; PRIORITY JOURNAL;

EID: 0030051849     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/76.1.23     Document Type: Article

References (36)

1. Coursin DB, Kelly JS, Prielipp RC. Muscle relaxants in critical care. Current Opinion in Anesthesiology 1993; 6: 341-346.
2. Partridge BL, Abrams JH, Bazemore C, Rubin R, Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Critical Care Medicine 1990; 18: 1177-1179.
3. Meyer KC, Prielipp RC, Grossman JE, Coursin DB. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesthesia and Analgesia 1994; 78: 772-774.
4. Hansen-Flaschen J, Cowen J, Raps EC. Neuromuscular blockade in the ICU. More than we bargained for. American Review of Respiratory Disease 1993; 147: 234-236.
5. Adams LJ. Neuromuscular blocking agents: a pharmacotherapeutic review. Hospital Pharmacy 1992; 27: 391-393, 396-400.
6. Pribble C, Timmons O, Moore M, Gooch J. Risk factors for prolonged weakness after vecuronium infusions in pediatric patients. Critical Care Medicine 1995: 23: A219.
7. Haynes SR, Morton NS. Prolonged neuromuscular blockade with vecuronium in a neonate with renal failure. Anaesthesia 1990; 45: 743-745.
8. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. New England Journal of Medicins 1992; 327: 524-528.
9. Sokoll MD, Gergis SD. Antibiotics and neuromuscular function. Anesthesiology 1981; 55: 148-159.
10. Coursin DB, Klasek G, Goelzer SL. Increased requirements for continuously infused vecuronium in critically ill patients. Anesthesia, and Analgesia 1989; 69: 518-521.
11. Goudsouzian NG, Young ET, Moss J, Liu LMP. Histamine release during the administration of atracurium or vecuronium in children. British Journal of Anaesthesia 1986; 58: 1229-1233.
12. Isenstein DA, Venner DS, Duggan J. Neuromuscular blockade in the intensive care unit. Chest 1992; 102: 1258-1266.
13. Fiamengo SA, Savarese JJ. Editorial. Use of muscle relaxants in intensive care units. Critical Care Medicine 1991; 19: 1457-1459.
14. Loper KA, Butler S, Nessly M, Wild L. Paralysed with pain: the need for education. Pain 1989; 37: 315-310.
15. Shann F, Duncan A, Butt W, Henning R, Smith M, Tibballs J. Drug Doses, 8th Edn. Australia: Collective Pty Ltd, 1994.
16. 2 anesthesia. Anesthesia and Analgesia 1989; 68: 20-24.
17. Fitzpatrick KTJ, Black GW, Crean PM, Mirakhur RK. Continous vecuronium infusion for prolonged muscle relaxation in children. Canadian Journal of Anaesthesia 1991; 38: 169-174.
18. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. Journal of the American Medical Association 1991; 266: 2870-2875.
19. Viby-Mogensen J. Monitoring neuromuscular function in the intensive care unit. Intensive Care Medicine 1993; 19: S74-S79.
20. Rudis M, Sikora CA, Angus E, Peterson E, Popovich J, Hyzy R, Zarowitz B. Vecuronium dosing by peripheral nerve stimulation results in lower paralytic doses but does not change recovery time in critically-ill medical patients. Critical Care Medicine 1995; 23: A72.
21. Harper NJN. Neuromuscular blocking drugs: practical aspects of research in the intensive care unit. Intensive Care Medicine 1993; 19; S80-S85.
22. Minitab Reference Manual PC Version Release 8. Rosemount PA: Quickset Inc., 1991; 14-4.
23. 2O halothane anesthesia. Anesthesiology 1983; 58: 519-523.
24. Goudsouzian NG, Martyn JJA, Liu LMP, Gionfriddo M. Safety and efficacy of vecuronium in adolescents and children. Anesthesia and Analgesia 1983; 62: 1083-1088.
25. Meistelman C, Loose JP, Saint-Maurice C, Delleur MM, da Suva GL. Clinical pharmacology of vecuronium in children. Studies during nitrous oxide and halothane in oxygen anaesthesia. British Journal of Anaesthesia 1986; 58: 996-1000.
26. Meretoja OA, Wirtavouri K, Neuvonen PJ. Age dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia. Anesthesia and Analgesia 1988; 67: 21-26.
27. Meretoja OA. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants? British Journal of Anaesthesia 1989; 62: 184-187.
28. Friis-Hansen B. Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. Pediatrics 1971; 47: 264-274.
29. Eldadah MK, Newth CJL. Vecuronium by continuous infusion for neuromuscular blockade in infants and children. Critical Care Medicine 1989; 17: 989-992.
30. Kalli I, Meretoja OA. Duration of vecuronium in infants and children anaesthetised without potent inhalation agents. Acta Anaesthesiologica Scandinavica 1989; 33: 29-33.
31. Smith CL, Hunter JM, Jones RS. Vecuronium infusions in patients with renal failure in an ITU. Anaesthesia 1987; 42: 387-393.
32. Segredo V, Matthay MA, Sharma ML, Gruenke LD, Caldwell JE, Miller RD. Prolonged neuromuscular blockade after long-term, administration of vecuronium in two critically ill patients. Anesthesiology 1990; 72: 566-570.
33. Henning RH, Wierda JMKH, Scaf AHJ, Marescau B, De Deyn PP, Agoston S. Increased sensitivity to vecuronium in patients with chronic renal failure. Drug Investigation 1993; 5: 98-107.
34. Hogue CW, Ward JM, Itani MS, Martyn JAJ. Tolerance and upregulation of acetylcholine receptors following chronic infusion of d-tubocurarine. Journal of Applied Physiology 1992; 72: 1326-1331.
35. Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects of neuromuscular blockers. Anesthesiology 1992; 76: 822-843.
36. Martineau RJ, St-Jean B, Kitts JB, Curran MC, Linday P, Hull KA, Miller DR. Cumulation and reversal with prolonged infusions of atracurium and vecuronium. Canadian Journal of Anaesthesia 1992; 39: 670-676.